Virogen Biotechnology Inc.
- Biotech or pharma, therapeutic R&D
Resimmune (VG712) is a best-in-class T cell depleting agent. Pivotal trial for CTCL approved by FDA. Preparing trials in preventing kidney transplant rejection, GVHD, solid tumor (combo therapy), and HIV. Seeking funding and collaboration partners.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}